Techniques in Vascular & Interventional Radiology
Volume 9, Issue 2 , Pages 80-83 , June 2006

Bivalirudin in Peripheral Interventions

  • Alexandra A. MacLean, MD

      Affiliations

    • Department of Surgery, New York Hospital–Queens, Flushing, New York.
    • ,
  • Constantino S. Peña, MD

      Affiliations

    • Vascular and Interventional Radiology, Baptist Cardiac and Vascular Institute, Miami, Florida.
    • ,
  • Barry T. Katzen, MD

      Affiliations

    • Vascular and Interventional Radiology, Baptist Cardiac and Vascular Institute, Miami, Florida.
    • Corresponding Author InformationAddress reprint requests to Barry T. Katzen, MD, Baptist Cardiac and Vascular Institute, 8900 North Kendall Drive, Miami, FL 33176.

References 

  1. Messmore HL, Wehrmacher WH, Coyne E, et al. Heparin to pentasaccharide and beyond: the end is not in sight. Semin Thromb Hemost. 2004;30(suppl 1):81–88
  2. Shammas NW. An overview of antithrombins in peripheral vascular interventions. J Invasive Cardiol. 2004;16(8):440–443
  3. Lincoff AM, Bittl JA, Kleiman NS, et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to reduced clinical events [REPLACE]-1 trial). Am J Cardiol. 2004;93(9):1092–1096
  4. Shammas NW, Lemke JH, Dippel EJ, et al. Bivalirudin in peripheral vascular interventions: a single center experience. J Invasive Cardiol. 2003;15(7):401–404
  5. Allie DE, Lirtzman MD, Wyatt CH, et al. Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions. J Invasive Cardiol. 2003;15(6):334–342
  6. Katzen BT, Ardid MI, MacLean AA, et al. Bivalirudin as an anticoagulant agent: safety and efficacy in peripheral interventions. J Vasc Interv Radiol. 2005;16:1183–1187
  7. Allie DE, Hall P, Shammas NW, et al. The angiomax peripheral procedure registry of vascular events trial (APPROVE): in-hospital and 30-day results. J Invasive Cardiol. 2004;16(11):651–656
  8. Bittl JA, Chaitman BR, Feit F, et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: final report reanalysis of the bivalirudin angioplasty study. Am Heart J. 2001;142:952–959
  9. Lincoff AM, Kleiman NS, Kottke-Marchant K, et al. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the comparison of abciximab complications with hirulog for ischemic events trial (CACHET). Am Heart J. 2002;143:847–853
  10. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003;289(7):853–863
  11. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355(21):2203–2216
  12. Nikolsky E, Dangas GD. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. Semin Thromb Hemostasis. 2004;30(3):305–314
  13. Mahaffey KW, Lewis BE, Wildermann NM, et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol. 2003;15:611–616
  14. Cochran K, DeMartini TJ, Lewis BE, et al. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia. J Invasive Cardiol. 2003;15:617–621
  15. Lewis BE, Matthai WH, Cohen M, et al. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv. 2002;57:177–184
  16. Mahaffey KW. Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Curr Cardiol Rep. 2001;3(5):362–370
  17. Grubbs G. Anticoagulation in peripheral interventions. Endovascular Today. 2003;1–4

 The authors have no financial disclosures and this work has not received funding.

PII: S1089-2516(06)00051-5

doi: 10.1053/j.tvir.2006.12.007

Techniques in Vascular & Interventional Radiology
Volume 9, Issue 2 , Pages 80-83 , June 2006

Article Tools